![Stuart Paynter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 700 973 $ al 31/05/2026
Stuart Paynter currently works at Oxxon Therapeutics Ltd., as Director from 2017, Oxford Biomedica (UK) Ltd., as Secretary & Director, Ceres Power Holdings plc, as Chief Financial Officer & Director from 2024, and The Institute of Chartered Accountants in England & Wales, as Member.
Mr. Paynter also formerly worked at STERIS Ltd., as Finance Director-European Region from 2001 to 2007, Shire Pharmaceuticals Ltd., as Senior Director-Finance Business from 2007 to 2016, Oxford Biomedica Plc, as Chief Financial Officer & Director from 2017 to 2024, and De La Rue Plc, as Head-Finance Business Partnering from 2016 to 2021.
Mr. Paynter received his undergraduate degree from Imperial College London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERES POWER HOLDINGS PLC 0,02 % | 31/12/2025 | 47.682 ( 0,02 % ) | 542 785 $ | 31/05/2026 |
OXFORD BIOMEDICA PLC 0,02 % | 31/12/2024 | 18.687 ( 0,02 % ) | 158 188 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CERES POWER HOLDINGS PLC | Director Financiero/CFO | 01/10/2024 |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
Oxford Biomedica (UK) Ltd.
 Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Develops novel gene therapy products and treatment for cystic fibrosis | Director/Miembro de la Junta | - |
Oxxon Therapeutics Ltd.
 Oxxon Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Director/Miembro de la Junta | 29/08/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Director Financiero/CFO | 02/09/2024 |
| DE LA RUE | Corporate Officer/Principal | 01/07/2021 |
Shire Pharmaceuticals Ltd.
 Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Director Financiero/CFO | 01/02/2016 |
STERIS Ltd.
 STERIS Ltd. Medical SpecialtiesHealth Technology Manufactures surgical and other medical supplies | Corporate Officer/Principal | 01/07/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Ceres Power Holdings plc
 Ceres Power Holdings plc Electronic Production EquipmentElectronic Technology Engages in development and commercialization of fuel cell technology | Electronic Technology |
STERIS Ltd.
STERIS Ltd. Medical SpecialtiesHealth Technology Manufactures surgical and other medical supplies | Health Technology |
De La Rue Plc
 De La Rue Plc Commercial Printing/FormsCommercial Services Designs, manufactures and delivers bank notes and provide authentication software | Commercial Services |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Oxxon Therapeutics Ltd.
Oxxon Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Oxford Biomedica (UK) Ltd.
Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Develops novel gene therapy products and treatment for cystic fibrosis | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
